These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33736662)
1. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature. Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662 [TBL] [Abstract][Full Text] [Related]
2. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Taylor J; McCluggage WG Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110 [TBL] [Abstract][Full Text] [Related]
3. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance]. Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536 [No Abstract] [Full Text] [Related]
4. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620 [TBL] [Abstract][Full Text] [Related]
5. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358 [TBL] [Abstract][Full Text] [Related]
6. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer? Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456 [TBL] [Abstract][Full Text] [Related]
7. Müllerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter. Watkins JC; Young RH Int J Gynecol Pathol; 2022 Jan; 41(1):68-75. PubMed ID: 33577227 [TBL] [Abstract][Full Text] [Related]
8. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis. Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670 [TBL] [Abstract][Full Text] [Related]
9. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy. Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911 [TBL] [Abstract][Full Text] [Related]
10. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic study of seromucinous carcinoma of ovary]. Tang SX; Sun YH; Xu Y; Zhou XR; Yang WT Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):774-779. PubMed ID: 27821232 [No Abstract] [Full Text] [Related]
12. Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion. Chen S; Leitao MM; Tornos C; Soslow RA Mod Pathol; 2005 Jul; 18(7):903-11. PubMed ID: 15696121 [TBL] [Abstract][Full Text] [Related]
13. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Lee KR; Nucci MR Int J Gynecol Pathol; 2003 Jan; 22(1):42-51. PubMed ID: 12496697 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas. Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965 [TBL] [Abstract][Full Text] [Related]
15. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature. Ates Ozdemir D; Usubutun A Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858 [TBL] [Abstract][Full Text] [Related]
16. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Bell KA; Kurman RJ Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848 [TBL] [Abstract][Full Text] [Related]
17. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary. Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452 [TBL] [Abstract][Full Text] [Related]
18. A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature. Newton CL; Brockbank E; Singh N; Faruqi A Int J Gynecol Pathol; 2017 Mar; 36(2):195-199. PubMed ID: 27362901 [TBL] [Abstract][Full Text] [Related]
19. Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues. Nagamine M; Mikami Y Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 32023964 [TBL] [Abstract][Full Text] [Related]